Xenagos Bio, Inc.

Biotechnology company · Philadelphia, Pennsylvania, United States

Xenagos Bio, Inc. is a biotechnology company headquartered in Philadelphia, Pennsylvania, United States. Its earliest recorded incorporation is in 2025. It has reported private securities offerings to the US SEC, most recently $2.5 million sold in a notice filed in 2026.

Profile compiled from public records. Is this your company? Request a correction or update

Xenagos Bio at a glance

Typebiotechnology company

HeadquartersPhiladelphia, Pennsylvania, United States

Earliest incorporation on record2025

SEC CIK2134608

What does Xenagos Bio do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $2.5 million sold (2026).

Frequently asked questions about Xenagos Bio

Where is Xenagos Bio headquartered?

Xenagos Bio, Inc. is headquartered in Philadelphia, Pennsylvania, United States.

What does Xenagos Bio do?

Xenagos Bio, Inc. is a biotechnology company.

When was Xenagos Bio founded?

The earliest incorporation on record for Xenagos Bio, Inc. is in 2025, according to public company registers.

Similar companies

Spark Therapeutics, Inc.Philadelphia, Pennsylvania, United States
Cabaletta Bio, Inc.Philadelphia, Pennsylvania, United States
Passage BIO, Inc.Philadelphia, Pennsylvania, United States
ZSX Medical, LLCPhiladelphia, Pennsylvania, United States
Enterin, Inc.Philadelphia, Pennsylvania, United States
Century Therapeutics, Inc.Philadelphia, Pennsylvania, United States
PolyCore Therapeutics, Inc.Philadelphia, Pennsylvania, United States
Five Eleven Pharma Inc.Philadelphia, Pennsylvania, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences